Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
460 Leser
Artikel bewerten:
(2)

Eastman Chemical to advance a circular future for healthcare packaging with key collaboration

Ethicon to source Eastman Renew materials in industry-leading move to help reduce plastic waste in healthcare

KINGSPORT, Tenn., Sept. 20, 2022 /PRNewswire/ -- Eastman (NYSE: EMN) has announced an agreement with Ethicon*, a Johnson & Johnson MedTech** Company, to source Eastman Renew materials for its medical device sterile-barrier packaging. This is an important step to help reduce waste in the healthcare system and contribute to a more circular future. With this agreement, Ethicon becomes the first healthcare company to use medical-grade Eastman Renew materials in its product packaging.

Ethicon to source Eastman Renew materials for its medical device sterile-barrier packaging to help reduce plastic waste in healthcare.

"The companies worked closely to chart a path toward creating a more circular future for packaging of medical devices, driving landfill diversion and reducing carbon emissions," said Scott Ballard, Eastman plastics division president. "With our molecular recycling technologies, we can improve the sustainability of products that have been the hallmark of safety and performance in healthcare for decades."

Powered by Eastman's innovative molecular recycling technologies, Ethicon will use Eastar Renew 6763 copolyester for its medical device sterile barrier packaging. Eastar Renew 6763 is indistinguishable from Eastar 6763 copolyester, with the same durability, safety and performance relied on by medical device companies for decades. The only difference is that by sourcing Eastar Renew, companies can certify that plastic waste is being diverted from landfills to produce new packaging. Through this agreement, the goal is to divert waste volume equal to 25% of the weight of total packaging produced - with the potential to increase up to 50% by the end of 2023.*** This commitment is backed by Ethicon's ISCC PLUS certification, awarded by the International Sustainability & Carbon Certification (ISCC), which traces sustainable sourcing of feedstock.

This is an important first step toward achieving circularity for healthcare packaging. Strategic collaborations like this will help drive change in the industry, leveraging molecular recycling to increase recycling rates and catalyze a circular economy for healthcare.

Eastman's molecular recycling technologies hold great promise for helping healthcare companies increase their sustainability profiles. Using mechanically recycled materials in healthcare applications is not possible due to stringent purity and transparency requirements. Eastman's molecular recycling technologies offer a path toward reducing plastic waste for the industry. By breaking down waste to its molecular building blocks, which are indistinguishable from virgin materials, they can be used to create high-performance polymers suitable for the medical industry. And because these technologies source plastic waste as feedstock, they leave fossil resources in the ground and result in lower greenhouse gas emissions.

Visit eastman.com/circular for more information on Eastman's efforts in the circular economy and Eastman Renew materials.

*Ethicon represents the products and services of Ethicon, Inc., Ethicon Endo-Surgery, LLC and certain of their affiliates. All other trademarks are the property of their respective owners.
**Johnson & Johnson MedTech comprise the surgery, orthopedics, vision and interventional solutions businesses within Johnson & Johnson's MedTech segment.

***The recycled content is achieved by allocating the recycled waste plastic to Eastman Renew materials using a mass balance process certified by ISCC.

About Eastman

Founded in 1920, Eastman is a global specialty materials company that produces a broad range of products found in items people use every day. With the purpose of enhancing the quality of life in a material way, Eastman works with customers to deliver innovative products and solutions while maintaining a commitment to safety and sustainability. The company's innovation-driven growth model takes advantage of world-class technology platforms, deep customer engagement, and differentiated application development to grow its leading positions in attractive end markets such as transportation, building and construction, and consumables. As a globally inclusive and diverse company, Eastman employs approximately 14,000 people around the world and serves customers in more than 100 countries. The company had 2021 revenues of approximately $10.5 billion and is headquartered in Kingsport, Tennessee, USA. For more information, visit?www.eastman.com.

Media Contact:

Eastman
Jacob Teetzmann
Tombras
jteetzmann@tombras.com
+1 423.494.3673

Eastman

Photo - https://mma.prnewswire.com/media/1902308/Eastman_Ethicon_Image.jpg
Logo - https://mma.prnewswire.com/media/746866/Eastman_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/eastman-to-advance-a-circular-future-for-healthcare-packaging-with-key-collaboration-301627686.html

Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2022 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.